Navigation Links
State of the Mangosteen Category: 2009
Date:3/6/2009

Research, Weber State University and leading independent laboratories, XanGo continues to spearhead scientific exploration of the whole mangosteen fruit through a tiered approach on safety, standardization and efficacy.

In XanGo's most recent independent research of the mangosteen completed in January 2009, promising peer-reviewed clinical trials by the UCLA School of Medicine's Dr. Jay K. Udani have shown that XanGo(R) Juice reduces inflammation in obese subjects, which may be valuable in preventing the progression to diabetes and heart disease. This eight-week randomized, double-blind, placebo-controlled study included a pre-study two-week washout period. It evaluated the effect of multiple dosages of a proprietary mangostoeen juice on indicators of inflammation and antioxidant levels in obese patients with elevated C-reactive protein (CRP) levels.

Previous independent research sponsored by XanGo has demonstrated that the proprietary whole fruit formula in XanGo Juice leads to high levels of xanthone absorption while unnaturally elevated levels of xanthone consumption actually were shown to decrease absorption efficiency.

XanGo is intent on continuing to lead the worldwide market in mangosteen-based research and category-creating mangosteen-based products. Expect more research in the coming years that continues to validate existing claims about the mangosteen and further product extensions that broaden the benefits of the mangosteen to myriad oral, topical and other wellness applications.

About XanGo

A leading global nutrition company, XanGo, LLC is a recognized category creator as the first company to market a premium mangosteen beverage, XanGo(R) Juice, to consumers worldwide. XanGo continues to lead the category by driving t
'/>"/>

SOURCE XanGo, LLC
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. AHIP Statement on White House Health Care Summit
2. Change to Win Statement on White House Health Care Forum
3. Statement by Bruce Bodaken, Chairman & CEO, Blue Shield of California, Regarding President Obamas Healthcare Summit
4. Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center
5. IPRO QIO Uses Milliman Care Guidelines(R) for Medicare Reviews in New York State
6. European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors
7. On March 4, 2009, The United States Supreme Court Rejected the Rationale Behind Michigans Drug Product Liability Law
8. AAJ Statement on Supreme Court Decision in Favor of Diana Levine
9. NJLRA Statement on Todays U.S. Supreme Courts Decision in Wyeth v. Levine
10. AAHSA Statement on Senate Special Committee on Aging Hearing, Health Reform in an Aging America
11. Naturally Safe Zucol(TM) Brings Europes Leading Cold Remedy to United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... In one of the most comprehensive analyses to ... prostate cancer, researchers at UPMC found that this now-dominant ... surgery, despite little scientific evidence of long-term improved patient ... and will appear in the July issue of the ... the first studies based on actual direct and indirect ...
(Date:5/23/2012)... and the American Health Care System was released by ... 1997 predecessor, the second edition textbook offers a comprehensive ... the U.S. health care system. Law and the American ... change in how health care is organized, financed, and ... focuses on how a dramatically changing legal environment influencesand ...
(Date:5/23/2012)... Karlstad University in Sweden shows that phthalates from PVC ... are substances suspected to cause asthma and allergies, as ... shows that children can ingest these softening agents with ... , Phthalates are a group of chemical compounds that ... common consumer goods such as toys, cleaning solvents, packaging, ...
(Date:5/23/2012)... , , TUESDAY, May 22 (HealthDay News) -- Patients ... which involves threading a camera through the colon ... a new study has found that patients overwhelmingly ... time-consuming CT-based colon scan. Colonoscopy has ... cancer screening. Computed tomography (CT) colonography -- sometimes ...
(Date:5/23/2012)... treatment with inhaled corticosteroids in patients with respiratory ... associated with a lower incidence and severity of ... researchers in Spain. , A parapneumonic effusion is ... accumulates between the two pleural layers, the fluid-filled ... a result of a pneumonia, lung abscess, or ...
Breaking Medicine News(10 mins):Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 3Health News:Landmark textbook on health care and the US legal system released 2Health News:Phthalates in PVC floors taken up by the body in infants 2Health News:Patients Prefer More Invasive Form of Colon Scan: Study 2Health News:Patients Prefer More Invasive Form of Colon Scan: Study 3Health News:Long-term ICS use reduces pleural effusion in patients with CAP 2
... Securities until February 15, ... ... KV Pharmaceutical Company,(NYSE: KVa/KVb) a fully integrated specialty pharmaceutical company that,develops, ... today that NYSE Regulation, Inc. has granted KV,s request for a,trading ...
... Recommendations cite importance of restricted calorie intake for diabetics ... (HealthDay News) -- For the first time, the American ... low-carbohydrate diets for people with diabetes who want to ... of low-calorie or low-carbohydrate diets in its ...
... PITTSBURGH, Dec. 28 Mylan Inc. (NYSE: MYL ... approval,from the U.S. Food and Drug Administration (FDA) for ... (OTC), 5 mg,and 10 mg., Cetirizine HCl Tablets ... U.S. sales of approximately $1.4 billion for the 12,months ...
... the United States, the management of glaucoma costs about ... direct costs, glaucoma medications account for an estimated 38% ... in the January 2008 issue of the American Journal ... Health Science Center College of Medicine, Temple, Texas; analyzed ...
... -- Featuring an Interactive Arcade for Kids, Teens, and ... Fitworks largest 59,000,sq. ft. Mega-Center officially opened for ... in West Chester just off Cincinnati-Dayton,Road & I-75 next ... for January which includes a silent auction on Saturday, ...
... Eclipsys Corporation(R),(Nasdaq: ECLP ), The Outcomes Company(R), ... JPMorgan Healthcare Conference taking place from,January 7th - ... http://www.newscom.com/cgi-bin/prnh/20050209/FLW006LOGO ), Eclipsys executives will present ... p.m. Pacific time. To access the live presentation ...
Other Medicine News:Health News:KV Pharmaceutical Company Announces NYSE Listing Extension 2Health News:KV Pharmaceutical Company Announces NYSE Listing Extension 3Health News: Diabetes Group Backs Low-Carb Diets 2Health News:Cost of glaucoma medications may impact treatment 2Health News:Fitworks West Chester Mega-Center Now Open 2Health News:Fitworks West Chester Mega-Center Now Open 3Health News:Eclipsys to Present at JPMorgan Healthcare Conference 2Health News:Eclipsys to Present at JPMorgan Healthcare Conference 3
(Date:5/22/2012)... AUSTIN, Texas, May 22, 2012 ... audio interview with Medical Marijuana, Inc. (PINKSHEETS: ... be heard at http://smallcapvoice.com/blog/5-21-12-smallcapvoice-interview-with-medical-marijuana-inc-pink-sheets-mjna . ... The company earned net income of ... $1.79 million for the quarter ended March ...
(Date:5/22/2012)... RICHMOND, Va., May 22, 2012 Health Diagnostic ... health management, has provided the National Lipid Association (NLA) ... to prevent cardiovascular diseases and improve cardiovascular health across ... Inc. will serve as one of the lead sponsors ... on May 31, 2012 to June 3, 2012. ...
(Date:5/22/2012)... 2012  Upsher-Smith Laboratories, Inc. announced today that ... prestigious McKesson Branded Pharmaceutical Representative of the Year ... in Las Vegas, NV on May 8, 2012.  ... Vice President of Purchasing at McKesson.  ... Francisco, CA-based McKesson, one of the largest pharmaceutical ...
Breaking Medicine Technology:Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 2Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 3Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 4Health Diagnostic Laboratory, Inc. Provides Grant to Support National Lipid Association, Sponsors 2012 Annual Scientific Sessions in Scottsdale, Arizona 2Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation 2Health Savings Account Enrollment Reaches Ten Million 72336 1Health Savings Account Enrollment Reaches Ten Million 72336 2ChemoCentryx President and CEO Thomas J Schall Ph D Named Ernst 26amp 3B Young Entrepreneur Of The Year 2010 Award Finalist in Northern Californ 16380 1ChemoCentryx President and CEO Thomas J Schall Ph D Named Ernst 26amp 3B Young Entrepreneur Of The Year 2010 Award Finalist in Northern Californ 16380 2ChemoCentryx President and CEO Thomas J Schall Ph D Named Ernst 26amp 3B Young Entrepreneur Of The Year 2010 Award Finalist in Northern Californ 16380 3ChemoCentryx President and CEO Thomas J Schall Ph D Named Ernst 26amp 3B Young Entrepreneur Of The Year 2010 Award Finalist in Northern Californ 16380 4Large Meta Analysis Further Validates Benefit of Measuring Lp PLA2 for Coronary Heart Disease and Ischemic Stroke Risk Assessment 8971 1Large Meta Analysis Further Validates Benefit of Measuring Lp PLA2 for Coronary Heart Disease and Ischemic Stroke Risk Assessment 8971 2Large Meta Analysis Further Validates Benefit of Measuring Lp PLA2 for Coronary Heart Disease and Ischemic Stroke Risk Assessment 8971 3
... Regimens, SAN MARINO, Calif., April 21 ... an on-going Phase I/II,study of Rexin-G for pancreatic ... in patients with metastatic,chemotherapy-resistant pancreatic cancer. The clinical ... ranging from 1 x 10e11,cfu twice a week ...
... 21 On Tuesday, April 15th, Lee S.,Schwartzberg, ... Network, Inc. presented findings at the American Association ... Phase II study tested a,novel biologic agent in ... interim results. More specifically, this Phase II,study was ...
Other Medicine Technology:Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer 2ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research 2ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research 3
... Hamilton is precision, ergonomics, and value!, ... fatigue with soft non-slip, contoured handle ... smooth, light plunger spring action , ... sterilization without the need for recalibration ...
... The AlphaPette Pipettor is the ... beyond. Offers accuracy, comfort, and reliability. ... digital volume readout sub-micrometer. Easy interchangeable ... or tiny hands. Adjustable rapid pipet ...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Research Series 2100 Adjustable-volume Pipette, 2.0-20 l, single-channel with adjustable-volume setting...
Medicine Products: